5-NItro-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACNEZL798
CAS No. :
1353762-30-7
Molecular Formula :
C11H16BN3O4
Molecular Weight :
265.08

IUPAC Name:5-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

5-NItro-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$411.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-NItro-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC Name5-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
MDL No.MFCD27936370
Molecular FormulaC11H16BN3O4
Molecular Weight265.08
SMILESCC1(OB(C2=CC([N+]([O-])=O)=CN=C2N)OC1(C)C)C
InChI KeyRZZBZVXUOALMBY-UHFFFAOYSA-N
Synonym2-Pyridinamine, 5-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;5-Nitro-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
CAS No.1353762-30-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNEZL798 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACUCYR560 route compound structure diagram
    ACUCYR56015862-31-4 In Stock
  4. Then
  5. ACNEZL798 route product structure diagram
    ACNEZL7981353762-30-7
Inquiry

2. ACNEZL798 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACGIRM794 route compound structure diagram
    ACGIRM79425391-56-4 In Stock
  4. Then
  5. ACNEZL798 route product structure diagram
    ACNEZL7981353762-30-7
Inquiry

Comments (0)